ARTICLE | Company News
Affibody, Algeta deal
March 11, 2013 7:00 AM UTC
Algeta disclosed in its 2012 earnings that in February it deemed platelet derived growth factor receptor B ( PDGFRB; PDGFR1; CD140B) an unsuitable target for alpha-pharmaceutical development and te...